Tianjin Medical University Cancer Institute & Hospital: Clinical Trials & Research Profile
Academic Medical Center in Tianjin, China · Primary Specialty: Oncology and Hematology
| Clinical Trial Metric | Verified Public Record |
|---|---|
| Organization Type | Clinical Trial Research Site |
| Institutional Sector & Location | Academic Medical Center (Tianjin, China) |
| Primary Therapeutic Area | Oncology and Hematology |
| Active Phase II & III Studies | 170 active (75 recruiting now) |
| Total Tracked Studies (2018 to 2026) | 235 |
| Completed vs Early-Stopped Studies | 24 completed / 11 stopped (4.7% stop rate) |
| Median Closed Enrollment | 178 participants |
| Median Completed Study Duration | 1,277 calendar days |
| Physical Hospital Site Disclosure | 100.0% named hospital campus |
Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI -> · AI for Healthcare · Healthcare Price & Patent Cliff Crosswalk